Reduced antioxidant defense systems in schizophrenia and bipolar I disorder

被引:90
|
作者
Raffa, Monia [2 ]
Barhoumi, Sana [2 ]
Atig, Fatma [2 ]
Fendri, Chiraz [1 ]
Kerkeni, Abdelhamid [2 ]
Mechri, Anwar [1 ,3 ]
机构
[1] Univ Monastir, Fac Med, Res Lab Vulnerabil Psychot Disorders, Monastir 5000, Tunisia
[2] Univ Monastir, Res Lab Trace Elements Free Rad & Antioxidants, Dept Biophys, Fac Med, Monastir 5000, Tunisia
[3] Univ Monastir, Univ Hosp Monastir, Dept Psychiat, Res Lab Vulnerabil Psychot Disorders,Fac Med, Monastir 5000, Tunisia
关键词
Antioxidant enzymes; Bipolar disorder; Glutathione; Oxidative stress; Schizophrenia; SERUM SUPEROXIDE-DISMUTASE; ACID REACTIVE SUBSTANCES; OXIDATIVE STRESS; LIPID-PEROXIDATION; GLUTATHIONE-PEROXIDASE; NITRIC-OXIDE; ENZYME-ACTIVITIES; DIFFERENT FORMS; CORTEX; MALONDIALDEHYDE;
D O I
10.1016/j.pnpbp.2012.07.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Numerous evidence and proofs suggest that the oxidative stress contributes to the pathogenesis of schizophrenia (SZ) and bipolar disorder (BD). The aim of this study is to determine the glutathione levels and the antioxidant enzyme activities in blood samples of patients suffering from SZ and patients with bipolar disorder in comparison with the healthy controlled subjects. It was a case-controlled study carried on upon three groups: forty-six SZ patients (41 men and 5 women, mean age = 33.2 +/- 7 years), thirty BD patients (25 men and 5 women, mean age = 31.3 +/- 8 years) and forty healthy controls (33 men and 7 women, mean age = 32.3 +/- 7 years). The glutathione levels are the total glutathione (GSHt), the reduced glutathione (GSHr), and the oxidized glutathione (GSSG) and the antioxidant enzyme activities that are the superoxide dismutase (SOD), the glutathione peroxidase (GPx), and the catalase (CAT) are determined by the spectrophotometer. We noticed that the GSHt and the GSHr levels significantly decreased in both SZ and BD patients in comparison with the healthy control subjects. As for SOD and CAT activities they remained lower for the patients with SZ when compared both with the controls or the BD patients. We noticed as well that the CAT activity was significantly lower in the BD group than that in the control group, whereas, GPx activity showed no significant change in each group. Hence, this report of the decreased plasma levels of GSHt and GSHr, and the impaired antioxidant enzyme activities in SZ and BD patients aims at highlighting the GSH deficit that seems to be contributing to these disorders, and showing that it may be an important indirect biomarker of the oxidative stress for the SZ and BD. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 50 条
  • [1] Glutathione as an Antioxidant Defense System in Schizophrenia and Bipolar 1 Disorder
    Fathy, H.
    Bayoumy, H.
    Mawla, S. Abdel
    Aladrousy, M.
    Alhanafy, H.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [2] Reduced Fertility and Fecundity among Patients with Bipolar I Disorder and Schizophrenia in Egypt
    Mansour, Hader
    Kandil, Kareem
    Wood, Joel
    Fathi, Warda
    Elassy, Mai
    Ibrahim, Ibtihal
    Salah, Hala
    Yassin, Amal
    Elsayed, Hanan
    Tobar, Salwa
    El-Boraie, Hala
    Eissa, Ahmed
    Elhadidy, Mohamed
    Ibrahim, Nahed E.
    El-Bahaei, Wafaa
    Nimgaonkar, Vishwajit L.
    PSYCHIATRY INVESTIGATION, 2011, 8 (03) : 214 - 220
  • [3] Reduced Fertility and Fecundity among Patients with Bipolar I Disorder and Schizophrenia in Egypt
    Mansour, Hader
    Kandil, Kreem
    Wood, Joel
    Nimgaonkar, Vishwajit
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 123S - 123S
  • [4] Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione
    Das, Tushar Kanti
    Javadzadeh, Alborz
    Dey, Avyarthana
    Sabesan, Priyadharshini
    Theberge, Jean
    Radua, Joaquim
    Palaniyappan, Lena
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2019, 91 : 94 - 102
  • [5] Free radicals, antioxidant defense systems, and schizophrenia
    Wu, Jing Qin
    Kosten, Thomas R.
    Zhang, Xiang Yang
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 46 : 200 - 206
  • [6] Olanzapine In Adolescents with Schizophrenia or Bipolar I Disorder
    McCormack, Paul L.
    CNS DRUGS, 2010, 24 (05) : 443 - 452
  • [7] OlanzapineIn adolescents with schizophrenia or bipolar I disorder
    Paul L. McCormack
    CNS Drugs, 2010, 24 : 443 - 452
  • [8] Cariprazine (Vraylar) for Schizophrenia and Bipolar I Disorder
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1493): : 51 - 53
  • [9] Schizophrenia, bipolar disorder and chromosome I linkage
    Macgregor, S
    Visscher, P
    Knott, S
    Thompson, P
    Millar, K
    Porteous, D
    Muir, W
    Blackwood, D
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 114 (07): : 722 - 723
  • [10] A Systems Neuroscience Perspective of Schizophrenia and Bipolar Disorder
    Frangou, Sophia
    SCHIZOPHRENIA BULLETIN, 2014, 40 (03) : 523 - 531